Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IND. SWIFT SUN PHARMA IND. SWIFT/
SUN PHARMA
 
P/E (TTM) x 3.3 43.2 7.7% View Chart
P/BV x - 6.9 - View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 IND. SWIFT   SUN PHARMA
EQUITY SHARE DATA
    IND. SWIFT
Mar-23
SUN PHARMA
Mar-23
IND. SWIFT/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs151,072 1.4%   
Low Rs7790 0.8%   
Sales per share (Unadj.) Rs75.9182.9 41.5%  
Earnings per share (Unadj.) Rs4.835.7 13.5%  
Cash flow per share (Unadj.) Rs10.146.2 21.9%  
Dividends per share (Unadj.) Rs011.50 0.0%  
Avg Dividend yield %01.2 0.0%  
Book value per share (Unadj.) Rs-130.1233.4 -55.8%  
Shares outstanding (eoy) m54.162,399.34 2.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.15.1 2.7%   
Avg P/E ratio x2.226.1 8.4%  
P/CF ratio (eoy) x1.020.1 5.2%  
Price / Book Value ratio x-0.14.0 -2.0%  
Dividend payout %032.2 0.0%   
Avg Mkt Cap Rs m5722,233,361 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m63782,960 0.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,110438,857 0.9%  
Other income Rs m1198,199 1.4%   
Total revenues Rs m4,228447,055 0.9%   
Gross profit Rs m1,026112,900 0.9%  
Depreciation Rs m28725,294 1.1%   
Interest Rs m5981,720 34.7%   
Profit before tax Rs m26094,084 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m08,476 0.0%   
Profit after tax Rs m26085,608 0.3%  
Gross profit margin %25.025.7 97.1%  
Effective tax rate %09.0 0.0%   
Net profit margin %6.319.5 32.5%  
BALANCE SHEET DATA
Current assets Rs m2,734398,619 0.7%   
Current liabilities Rs m9,363199,064 4.7%   
Net working cap to sales %-161.345.5 -354.8%  
Current ratio x0.32.0 14.6%  
Inventory Days Days115147 78.3%  
Debtors Days Days92995 976.4%  
Net fixed assets Rs m3,758376,960 1.0%   
Share capital Rs m1082,399 4.5%   
"Free" reserves Rs m-7,155557,555 -1.3%   
Net worth Rs m-7,047559,954 -1.3%   
Long term debt Rs m4,0310-   
Total assets Rs m6,492775,794 0.8%  
Interest coverage x1.455.7 2.6%   
Debt to equity ratio x-0.60-  
Sales to assets ratio x0.60.6 111.9%   
Return on assets %13.211.3 117.4%  
Return on equity %-3.715.3 -24.2%  
Return on capital %-28.417.1 -166.3%  
Exports to sales %68.80-   
Imports to sales %5.30-   
Exports (fob) Rs m2,827NA-   
Imports (cif) Rs m217NA-   
Fx inflow Rs m2,947154,053 1.9%   
Fx outflow Rs m31371,511 0.4%   
Net fx Rs m2,63482,541 3.2%   
CASH FLOW
From Operations Rs m73049,593 1.5%  
From Investments Rs m-293-79,437 0.4%  
From Financial Activity Rs m-46623,761 -2.0%  
Net Cashflow Rs m-291,155 -2.5%  

Share Holding

Indian Promoters % 55.6 54.5 102.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 36.6 -  
FIIs % 0.0 17.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.4 45.5 97.6%  
Shareholders   14,219 612,626 2.3%  
Pledged promoter(s) holding % 42.8 2.4 1,754.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IND. SWIFT With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on IND. SWIFT vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IND. SWIFT vs Sun Pharma Share Price Performance

Period IND. SWIFT Sun Pharma S&P BSE HEALTHCARE
1-Day 8.28% 0.77% 1.18%
1-Month -2.97% 3.00% -0.75%
1-Year 161.80% 64.65% 61.82%
3-Year CAGR 59.03% 39.45% 18.16%
5-Year CAGR 27.79% 27.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the IND. SWIFT share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of IND. SWIFT hold a 55.6% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IND. SWIFT and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, IND. SWIFT paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of IND. SWIFT, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.